Gene therapy preparations manufacturing · New Jersey

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing

Summit, NJ · ~3,075 workers · 3 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
0.6
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing runs at 17% of its industry's injury rate - far safer than the typical Gene therapy preparations manufacturing workplace, earning a grade A.

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing: 0.6 TCR = 17% of Gene therapy preparations manufacturing BLS 3.3 · 3y Form 300A (see methodology below)

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing safety composite

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing scores strongest on total case rate (tcr) (safer than 76% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

C

64/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
B 0.55 per 100 workers

Safer than 76% of industry peers

DART rate
C 0.24 per 100 workers

Safer than 60% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing held a steady TCR band

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing's TCR held near 0.2 from 0.5 in 2022 to 0.3 in 2024. Peak filing year was 2023 at 0.8 TCR. In 2024, DART was 0.44× this establishment's average TCR (severity share of cases).

2022=0.5 · 2023=0.8 · 2024=0.3

OSHA ITA Form 300A scorecard

Establishment book 325414 · Summit, NJ AT/BELOW-IND · LARGE

Grade A · TCR 0.6 · 17% of ind

  • DART 0.2 DART
  • RANK #3/9
  • PHOTO Thermo Fisher Scient…
  • BOOK 3y book
  • INJ 42 inj
  • SIZE ~3,075 FTE

Nearest TCR peer: Thermo Fisher Scientific (0.0 TCR gap)

Read with this employer → · Industry book → · New Jersey employers → · Look up another →

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Bristol Myers Squibb - Summit West Cell Therapy Manufacturing averages 0.6 TCR (17% of the Gene therapy preparations manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing TCR series: 2022=0.5 · 2023=0.8 · 2024=0.3 · BLS 3.3

Where Bristol Myers Squibb - Summit West Cell Therapy Manufacturing falls in its industry

234 Gene therapy preparations manu establishments

Safer than 76% of graded establishments in this industry, whose median TCR is 1.2.

More dangerous than peersSafer than peers

Narrower to New Jersey alone (the establishments it most directly competes with for workers and contracts): ranked #3 safest of 9 Gene therapy preparations manu employers in New Jersey.

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing (3,075 employees, TCR 0.6) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 0246 Average employees Total Case Rate Bristol Myers Squibb - Summit West Cell Therapy Manufacturing
Bristol Myers Squibb - Summit West Cell Therapy Manufacturing (3,075 employees, TCR 0.6) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2

Bristol Myers Squibb - Summit West Cell Therapy Manufacturing has more employees than the Gene therapy preparations manufacturing median and a lower injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.3 0.2 9 1 0
2023 0.8 0.6 20 5 0
2022 0.5 0.5 13 5 0

OSHA ITA peer cross-reference

Establishment peer ledger

325414 · NJ · Summit

234 Gene therapy preparations manufacturing employers nationwide with a credible TCR · 11,201 rated employers in New Jersey with headcount on file · 26 employers in Summit, NJ · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Thermo Fisher Scientific 0.6 TCR
NAICS-TCR Shire: 55 Network Drive 0.6 TCR
NAICS-TCR Merck Teknika Facility 0.5 TCR
NAICS-TCR Spark Therapeutics, Inc 0.5 TCR
STATE-SIZE Englewood Hospital and Medical Center 3,071 FTE
STATE-SIZE North America Fulfillment Centers (FCs) : EWR9 3,039 FTE
STATE-SIZE Skanska USA Building Inc. 3,124 FTE
STATE-SIZE Novo Nordisk Inc. 3,125 FTE
CITY-NEAR Overlook Medical Center 3,560 FTE
CITY-NEAR Celgene Corp. - Summit East 1,888 FTE
CITY-NEAR Celgene Corp. - Summit West 1,416 FTE
CITY-NEAR 2576-07551480-1480 824 FTE
NAT-TCR Berry Global - Danville, KY 0.6 TCR
NAT-TCR RCN Telecom Services, LLC-Norhampton 0.6 TCR
NAT-TCR Nbcorp-B5510-New Braunfels Corporate 0.6 TCR
NAT-TCR West Valley UT Millwork 0.6 TCR
NAT-SIZE Evanston Hospital 3,075 FTE
NAT-SIZE Main Hospital Campus 3,076 FTE
NAT-SIZE Pennsylvania Hospital 3,072 FTE
NAT-SIZE Shambaugh & Son LP 3,072 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2022. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details.